LMU Munich- Start of a new trial site

On 10 April 2026, the LMU Munich became officially another active trial site of the STOP-PKD Study. The team of Prof. Michael Fischereder cares for patients with a wide range of nephrological issues, including those affected by autosomal dominant polycystic kidney disease (ADPKD).

Interested patients can now make an appointment at the trial site in Munich to obtain detailed information about the trail and potential participation.

Phone: +49 89-4400 72372

Email: NephroStudien-GH@med.uni-muenchen.de